• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42055080-120
Device Problems Difficult or Delayed Activation (2577); Defective Device (2588)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/18/2020
Event Type  malfunction  
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents.The investigation determined that the reported deployment difficulty and stent shortening were likely the result of anatomical challenges.Forward/pushing motion on the delivery system during stent deployment while attempting to place in the 90% stenosed, moderately tortuous, heavily calcified lesion may have caused shortening of the stent.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
It was reported that the procedure was performed to treat a 90% stenosed, moderately tortuous, and heavily calcified lesion in the superficial femoral artery.A 6fr 45cm sheath was advanced through the 5.5mm vessel.Following pre-dilatation with a 5.5x80mm armada 18 balloon catheter, a 5.5x80mm supera self-expanding stent system (sess) was advanced.During deployment of the sess the stent became compressed greater than 10% and did not cover the entire lesion.The stent remained within the target lesion and the delivery system was removed under fluoroscopy.A 5.5x100mm supera stent was deployed overlapping the existing stent to fully cover the lesion.The patient is doing fine.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key9824677
MDR Text Key183158608
Report Number2024168-2020-02336
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 03/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/12/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2021
Device Catalogue Number42055080-120
Device Lot Number9061361
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/18/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/13/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE WIRE: COMMAND; SHEATH: 6FR CROSS OVER LENGTH 45CM
Patient Age65 YR
Patient Weight80
-
-